AI Market Mood: Stock Dashboard
GSK
Fundamental
Technical:
Latest News:
Sensitive Toothpaste Market to Grow by USD 1.30 Billion (2024-2028), Driven by ... - PR Newswire neutral
CL GSK PG
Summary: The global sensitive toothpaste market is estimated to grow by USD 1.30 billion from 2024-2028, driven by innovations and product line extensions introducing multifunctional toothpaste. However, challenges include high adoption of homemade remedies and alternative products. Market players like Colgate Palmolive Co., The Procter and Gamble Co., and GlaxoSmithKline Plc. are focusing on expanding their customer base and using effective marketing strategies.
Full articleBiopharmaceuticals Market Projected To Witness Substantial Growth, 2024-2031: Pfizer Inc ... neutral
AMGN ABBV GSK PFE NVO NVS JNJ LLY BMY RHHBY
Summary: The latest report on the Biopharmaceuticals Market provides a comprehensive analysis of the industry, including market size, trends, competitive landscape, and future growth prospects.
Full articleFrontotemporal Disorders Treatment Industry Research Study |GlaxoSmithKline, Pfizer, Sanofi somewhat bullish
GSK PFE SNY
Summary: A recent market research study by Orbis Research delves into the Frontotemporal Disorders Treatment market across various regions and includes detailed insights on growth rates, market trends, and key players such as GlaxoSmithKline, Pfizer, Sanofi, and more.
Full articleGilead (GILD) Announces Data on CAR T Therapy Candidate - Yahoo Movies UK somewhat bullish
GILD GSK NVS SGMO
Summary: Kite, a Gilead Sciences company, announced updated results from a phase I/II study, ZUMA-3, on experimental candidate KTE-X19 at the Annual Meeting of the American Society of Hematology. Gilead's stock has gained 2.7% in the past six months, worse than the industry's decline of 6.5%. Gilead currently carries a Zacks Rank #1 (Strong Buy).
Full articleUK Chooses Pfizer Over GSK for Multi-Million Dose RSV Vaccine Contract By Benzinga somewhat bullish
PFE GSK
Summary: Pfizer has secured a major contract with the U.K. to supply millions of doses of its Abrysvo RSV vaccine, edging out GSK. The agreement includes doses for older adults and pregnant mothers. Pfizer's Abrysvo is approved for use in pregnant women and the elderly, while GSK's Arexvy is only approved for older adults.
Full articleAplastic Anemia Market Analysis By Top Keyplayers - Pfizer, - openPR.com neutral
PFE BAYN NVO SHPG AMGN GSK
Summary: The Aplastic Anemia Market is projected to reach USD xx.x billion by 2031, with a CAGR growth rate from 2024 to 2031. The market analysis includes insights into competition, geographical research, recent developments, and factors impacting growth.
Full articleLilly doubles down on radiopharma - STAT News neutral
AZN BMY GSK
Summary: AstraZeneca aims to deliver $80 billion in total revenue by 2030 with new growth from 20 new medicines, Bristol Myers Squibb's FDA decision date for Opdivo moved forward, GSK's success with new asthma treatment in Phase 3 trials.
Full articlePfizer Zantac Settlement Payouts Will Total Up to $250M for Users Diagnosed with Cancer: Reports neutral
GSK PFE
Summary: Judge Rosenberg's ruling in the federal court system excludes all Zantac cancer lawsuits plaintiffs' expert witnesses, impacting pending lawsuits in federal court but not in Illinois, Delaware, and other state courts. Pfizer agrees to Zantac settlement payouts totaling between $200-250 million for about 10,000 former users, with average payout per claim expected between $20,000 and $25,000. Over 70,000 claims remain unresolved, mostly in Delaware state court.
Full articlePfizer to pay $250M over Zantac cancer risk lawsuits - Audacy somewhat bearish
PFE GSK SANOFI MRK BMY
Summary: Pfizer to pay $250 million to settle over 10,000 lawsuits related to Zantac, a heartburn drug linked to cancer risk, with ongoing discussions and legal battles among pharmaceutical companies related to the drug's liability.
Full articleAmazon, Microsoft, Pfizer To Invest Billions In French Projects - Forex News by FX Leaders very bullish
amzn msft pfe azn gsk acn
Summary: Major companies including Amazon, Microsoft, Pfizer, AstraZeneca, GSK, and Accenture have announced significant foreign investments in France totaling over $16.2 billion, creating jobs and focusing on AI and healthcare sectors.
Full articleInhaler Corticosteroid Device Market Projected Growth Outlined by Size, Share and ... - WhaTech somewhat bullish
PFE GSK NVS MYL TEVA SNY BAH AZN RHHBY BMY AMGN ABDNY LLY
Summary: The Global Inhaler Corticosteroid Device Market is valued at US$ 616.09 Mn in 2023 and expected to reach US$ 886.4 Mn by 2031 with a CAGR of 4.6% during 2024-2031 due to the rising prevalence of asthma, increasing pollution, and growth in healthcare expenditure.
Full articlePfizer Agrees To Settle Over 10000 Lawsuits About Cancer Risks Associated With ... somewhat bearish
PFE SNY GSK
Summary: Pfizer Inc has settled 10,000 lawsuits related to cancer risks of Zantac medication, but exposure to claims remains. Concerns over Zantac litigations led to a $45 billion market value loss in 2022 for drugmakers. Legal challenges continue despite recent legal victories.
Full article